tiprankstipranks
Advertisement
Advertisement

BBIO Stock Latest News

BridgeBio Pharma doses first patient in ASCEND-ATTR trial
The FlyBridgeBio Pharma doses first patient in ASCEND-ATTR trial
6h ago
BBIO
BridgeBio Pharma participates in a conference call with Cantor
PremiumThe Fly
BridgeBio Pharma participates in a conference call with Cantor
2d ago
BBIO
BridgeBio Pharma Earnings Call Signals Growth Amid Risks
PremiumCompany Announcements
BridgeBio Pharma Earnings Call Signals Growth Amid Risks
4d ago
BBIO
BridgeBio Pharma announces major secondary share offering
PremiumCompany Announcements
BridgeBio Pharma announces major secondary share offering
9d ago
8K
BBIO
BridgeBio price target raised to $94 from $93 at Citi
PremiumThe Fly
BridgeBio price target raised to $94 from $93 at Citi
9d ago
BBIO
BridgeBio price target raised to $106 from $104 at Canaccord
PremiumThe FlyBridgeBio price target raised to $106 from $104 at Canaccord
9d ago
BBIO
BridgeBio price target raised to $111 from $100 at JPMorgan
Premium
The Fly
BridgeBio price target raised to $111 from $100 at JPMorgan
9d ago
BBIO
BridgeBio price target raised to $107 from $102 at Truist
Premium
The Fly
BridgeBio price target raised to $107 from $102 at Truist
9d ago
BBIO
BridgeBio Oncology announces 5M common stock offering for holders
PremiumThe Fly
BridgeBio Oncology announces 5M common stock offering for holders
10d ago
BBIO
BridgeBio 5M share Spot Secondary priced at $78.00
PremiumThe Fly
BridgeBio 5M share Spot Secondary priced at $78.00
10d ago
BBIO
BridgeBio’s New Series A Preferred Stock Heightens Capital Structure Risk and Dilution Threat for Common Shareholders
PremiumCompany Announcements
BridgeBio’s New Series A Preferred Stock Heightens Capital Structure Risk and Dilution Threat for Common Shareholders
14d ago
BBIO
BridgeBio Earns Buy Rating on Attruby Outperformance and Multibillion-Dollar Growth Visibility
PremiumRatings
BridgeBio Earns Buy Rating on Attruby Outperformance and Multibillion-Dollar Growth Visibility
15d ago
BBIO
BridgeBio price target raised to $110 from $95 at TD Cowen
PremiumThe FlyBridgeBio price target raised to $110 from $95 at TD Cowen
15d ago
BBIO
BridgeBio price target lowered to $97 from $98 at Morgan Stanley
Premium
The Fly
BridgeBio price target lowered to $97 from $98 at Morgan Stanley
15d ago
BBIO
BridgeBio price target raised to $102 from $98 at Wells Fargo
Premium
The Fly
BridgeBio price target raised to $102 from $98 at Wells Fargo
15d ago
BBIO
BridgeBio price target raised to $115 from $111 at Piper Sandler
PremiumThe Fly
BridgeBio price target raised to $115 from $111 at Piper Sandler
15d ago
BBIO
BridgeBio price target raised to $104 from $101 at BofA
PremiumThe Fly
BridgeBio price target raised to $104 from $101 at BofA
15d ago
BBIO
BridgeBio reports Q2 EPS (78c), consensus (58c)
PremiumThe Fly
BridgeBio reports Q2 EPS (78c), consensus (58c)
16d ago
BBIO
Is BBIO a Buy, Before Earnings?
PremiumPre-Earnings
Is BBIO a Buy, Before Earnings?
18d ago
BBIO
BridgeBio: Buy Rating Backed by Attruby’s Multi‑Billion Peak Sales Potential and De‑Risked Launch Portfolio
PremiumRatingsBridgeBio: Buy Rating Backed by Attruby’s Multi‑Billion Peak Sales Potential and De‑Risked Launch Portfolio
23d ago
BBIO
BridgeBio files to sell 24.63M shares of common stock for holders
Premium
The Fly
BridgeBio files to sell 24.63M shares of common stock for holders
1M ago
BBIO
Analyst Reiterates Buy on BridgeBio, Maintaining $120 Price Target as Late-Stage Rare Disease Pipeline Advances
Premium
Ratings
Analyst Reiterates Buy on BridgeBio, Maintaining $120 Price Target as Late-Stage Rare Disease Pipeline Advances
1M ago
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >